Cargando…
Advances in Acute Myeloid Leukemia: Recently Approved Therapies and Drugs in Development
SIMPLE SUMMARY: Acute myeloid leukemia (AML) is one of the most common types of leukemia in adults, with an average first diagnosis at age 68, and has historically carried poor prognosis due to various genetic alterations and abnormalities that complicate approaches to treatment. Recently, numerous...
Autores principales: | Stanchina, Michele, Soong, Deborah, Zheng-Lin, Binbin, Watts, Justin M., Taylor, Justin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692236/ https://www.ncbi.nlm.nih.gov/pubmed/33139625 http://dx.doi.org/10.3390/cancers12113225 |
Ejemplares similares
-
Recent drug approvals for acute myeloid leukemia
por: Lai, Catherine, et al.
Publicado: (2019) -
Recent advances in the understanding and treatment of acute myeloid leukemia
por: Watts, Justin, et al.
Publicado: (2018) -
Profile of Glasdegib for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML): Evidence to Date
por: Iyer, Sunil Girish, et al.
Publicado: (2022) -
The treatment of acute promyelocytic leukemia in 2023: Paradigm, advances, and future directions
por: Iyer, Sunil Girish, et al.
Publicado: (2023) -
Recent advances in targeted therapies in acute myeloid leukemia
por: Bhansali, Rahul S., et al.
Publicado: (2023)